TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 1 | 11 | 8 | 60 | -24 | -27 | 5 |
| P | %wins | 100 | 100 | 100 | 100 | 0 | 0 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/8/24 18:23 | 1/5/24 | ZYME | Zymeworks Inc. | DE | Health | Drug | Pharmaceutical Preparations | Galbraith Kenneth | DE | DO | Chair,CE | M.d | 0 | 0.00 | 0 | 48 | 24 | D | |||||||||||||||
1/8/24 18:23 | 1/5/24 | ZYME | Zymeworks Inc. | DE | Health | Drug | Pharmaceutical Preparations | Galbraith Kenneth | DE | DO | Chair,CE | S.dm | -258 | 10.79 | 0 | -24 | -50 | 24 | D | ||||||||||||||
9/10/20 16:44 | 9/9/20 | MGNX | Macrogenics Inc | DE | Health | Drug | Pharmaceutical Preparations | Galbraith Kenneth | MD | D | M.d | 361 | 17.38 | 0 | 21 | 0 | D | ||||||||||||||||
9/10/20 16:44 | 9/9/20 | MGNX | Macrogenics Inc | DE | Health | Drug | Pharmaceutical Preparations | Galbraith Kenneth | MD | D | S.d | -563 | 27.11 | 0 | -21 | -100 | 0 | D | |||||||||||||||
10/18/13 14:36 | 10/16/13 | MGNX | Macrogenics Inc | DE | Health | Drug | Pharmaceutical Preparations | Galbraith Kenneth | MD | D | P.d | 750 | 16.00 | 28 | 47 | 4 | 1,317 | I | -1 | 1 | 11 | 8 | 60 | -24 | -27 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |